No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation

David Zweiker, Martin Manninger, Raphael Sieghartsleitner, Jakob Ebner, Bernadette Pratl, Egbert Bisping, Peter Lercher, Dirk von Lewinski, Rita Riedlbauer, Ursula Rohrer, Henri M H Spronk, Andreas Zirlik, Ulrich Schotten, Daniel Scherr

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)106-108
Number of pages3
JournalInternational Journal of Cardiology
Volume331
DOIs
Publication statusPublished - 15 May 2021

Keywords

  • Administration, Oral
  • Anticoagulants/therapeutic use
  • Atrial Fibrillation/diagnosis
  • Catheter Ablation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Stroke/drug therapy
  • Vitamin K/therapeutic use
  • Catheter ablation
  • Atrial fibrillation
  • Anticoagulation
  • Vitamin K antagonist
  • WARFARIN
  • Direct oral anticoagulants

Cite this